1
by Narain, Tasha, Adcock, Lorna
Published 2017
Canadian Agency for Drugs and Technologies in Health
...While each gene expression test has been independently clinically validated using prospective...

2
by Narain, Tasha, Adcock, Lorna
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Gene Expression Regulation, Neoplastic...

3
Published 2014
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Gene Expression Profiling...

4
Published 2014
Canadian Agency for Drugs and Technologies in Health
...Oncotype DX (ODX) is a gene expression profiling test designed to measure the 10-year risk of tumor...

5
by Janoudi, Ghayath, McCormack, Suzanne
Published 2020
Canadian Agency for Drugs and Technologies in Health
... protein. The number of available SMN2 gene copies and the extent of the expression of these genes modulate...

6
Published 2014
Canadian Agency for Drugs and Technologies in Health
... recurrence risk in order to support better decision-making about ACT. Gene-expression profiling (GEP...

7
Published 2014
Canadian Agency for Drugs and Technologies in Health
... recurrence risk in order to support better decision-making about ACT. Gene-expression profiling (GEP...